|
广西师范大学学报(自然科学版) ›› 2023, Vol. 41 ›› Issue (3): 155-162.doi: 10.16088/j.issn.1001-6600.2022042901
何柳1,2,3, 蔺超1,2,3, 李培华1,2,3, 陈治秀1,2,3, 朱宇1,2,3, 蒲仕明1,2,3, 周祖平1,2,3*
HE Liu1,2,3, LIN Chao1,2,3, LI Peihua1,2,3, CHENG Zhixiu1,2,3, ZHU Yu1,2,3, PU Shiming1,2,3, ZHOU Zuping1,2,3*
摘要: 为了解肺癌肿瘤组织白细胞介素-10(interleukin-10,IL-10)的表达和来源,并探究IL-10对肿瘤的作用,采用MSD 超敏电化学发光技术检测Lewis 肺癌小鼠模型血清中IL-10的水平,使用流式细胞术分析肿瘤组织IL-10的主要来源,再通过CCK-8实验、膜联蛋白V-碘化丙啶(annexin V-PI)凋亡实验、划痕实验,检测IL-10重组蛋白对肺癌细胞增殖、凋亡、迁移的影响。结果表明:Lewis肺癌小鼠血清中IL-10水平较正常小鼠显著升高,肿瘤组织中的IL-10主要由免疫细胞产生。其中,B细胞和髓源性抑制细胞(myeloid-derived suppressor cells,MDSCs)是IL-10的主要来源,IL-10重组蛋白可以显著抑制LLC(小鼠 Lewis 肺癌细胞:Lewis lung carcinoma line)的增殖和迁移并促进其凋亡。综上可见,IL-10水平与肺癌密切相关,B细胞和MDSCs是产生IL-10的主要来源,IL-10可能通过激活CD8 T细胞或者直接作用于肿瘤细胞而发挥抗肿瘤作用。
中图分类号: R734.2;Q28
[1] LEI L, YANG L Y, XU Y Y, et al. Hepatoid adenocarcinoma of the lung: an analysis of the surveillance, epidemiology, and end results (SEER) database[J]. Open Medicine, 2021, 16(1): 169-174. DOI: 10.1515/med-2021-0215. [2] HENLEY S J, WARD E M, SCOTT S, et al. Annual report to the nation on the status of cancer, part Ι: National cancer statistics[J]. Cancer, 2020, 126(10):2225-2249. DOI: 10.1002/cncr.32802. [3] SARAIVA M, O'GARRA A. The regulation of IL-10 production by immune cells[J].Nature Reviews Immunology, 2010, 10(3): 170-181. DOI: 10.1038/nri2711. [4] FILIPPI C M, VON HERRATH M G. IL-10 and the resolution of infections[J]. Journal of Pathology, 2008, 214(2): 224-230. DOI: 10.1002/path.2272. [5] RUTZ S, OUYANG W, CRELLIN N K, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease[J]. Annual Review of Immunology, 2011, 29(1): 71. DOI: 10.1146/annurev-immunol-031210-101312. [6] WANG X T, WONG K, OUYANG W J, et al. Targeting IL-10 family cytokines for the treatment of human diseases[J]. Cold Spring Harbor Perspectives in Biology, 2017, 11(2): a028548 DOI: 10.1101/cshperspect.a028548. [7] 周俊, 陈舒曼, 邢兵, 等. 正常来源CD4+CD25+细胞在小鼠肺癌模型中的抗肿瘤作用[J]. 广西师范大学学报(自然科学版), 2022, 40(2): 191-199. DOI: 10.16088/j.issn.1001-6600.2021022202. [8] OFT M. IL-10: master switch from tumor-promoting inflammation to antitumor immunity[J]. Cancer Immunology Research, 2014, 2(3): 194-199. DOI: 10.1158/2326-6066.CIR-13-0214. [9] KHODER A, SARVARIA A, ALSULIMAN A, et al. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD[J]. Blood, 2014, 124(13): 2034-2045. DOI: 10.1182/blood-2014-04-571125. [10] WU F Y, WANG L, ZHOU C C. Lung cancer in China: current and prospect[J].Current Opinion in Oncology, 2021, 33(1): 40-46. DOI: 10.1097/CCO.0000000000000703. [11] NOORELDEEN R, BACH H. Current and future development in lung cancer diagnosis[J]. International Journal of Molecular Sciences, 2021, 22(16):8661. DOI: 10.3390/ijms22168661. [12] MANNINO M H, ZHU Z W, XIAO H P, et al. The paradoxical role of IL-10 in immunity and cancer[J]. Cancer Letters, 2015, 367(2): 103-107. DOI: 10.1016/j.canlet.2015.07.009. [13] MIRLEKAR B. Tumor promoting roles of IL-10, TGF-β, IL-4, and IL-35: Its implications in cancer immunotherapy[J]. SAGE Open Medicine, 2022, 10: 20503121211069012. DOI: 10.1177/20503121211069012. [14] SARAIVA M, VIEIRA P, O'GARRA A. Biology and therapeutic potential of interleukin-10[J].Journal of Experimental Medicine, 2020, 217(1): e20190418. DOI: 10.1084/jem.20190418. [15] DABITAO D, HEDRICH C M, WANG F Y, et al. Cell-specific requirements for STAT proteins and Type I IFN receptor signaling discretely regulate IL-24 and IL-10 expression in NK cells and macrophages[J]. Journal of Immunology, 2018, 200(6): 2154-2164. DOI: 10.4049/jimmunol.1701340. [16] WANG X F, LI J, LU C H, et al. IL-10-producing B cells in differentiated thyroid cancer suppress the effector function of T cells but improve their survival upon activation[J]. Experimental Cell Research, 2019, 376(2): 192-197. DOI: 10.1016/j.yexcr.2019.01.021. [17] HU H T, AI X S, LU M X, et al. Characterization of intratumoral and circulating IL-10-producing B cells in gastric cancer[J]. Experimental Cell Research, 2019, 384(2): 111652. DOI: 10.1016/j.yexcr.2019.111652. [18] BATCHU R B, GRUZDYN O V, KOLLI B K, et al. IL-10 signaling in the tumor microenvironment of ovarian cancer[J]. Advances in Experimental Medicine and Biology, 2021, 1290: 51-65. DOI: 10.1007/978-3-030-55617-4_3. [19] POE S L, ARORA M, ORISS T B, et al. STAT1-regulated lung MDSC-like cells produce IL-10 and efferocytose apoptotic neutrophils with relevance in resolution of bacterial pneumonia[J]. Mucosal Immunology, 2013, 6(1): 189-199. DOI: 10.1038/mi.2012.62. [20] DIEFENHARDT P, NOSKO A, KLUGER M A, et al. IL-10 receptor signaling empowers regulatory T cells to control Th17 responses and protect from GN[J]. Journal of the American Society of Nephrology, 2018, 29(7):1825-1837. DOI: 10.1681/ASN.2017091044. [21] LI F Z, DHILLON A S, ANDERSON R L, et al. Phenotype switching in melanoma: implications for progression and therapy[J]. Frontiers in Oncology, 2015, 5:31. DOI: 10.3389/fonc.2015.00031. [22] PEREIRA A P L, TRUGILO K P, OKUYAMA N C M, et al. IL-10 c.-592C>A (rs1800872) polymorphism is associated with cervical cancer[J]. Journal of Cancer Research and Clinical Oncology, 2020, 146(8): 1971-1978. DOI: 10.1007/s00432-020-03256-0. [23] MOGHIMI M, AHRAR H, KARIMI-ZARCHI M, et al. Association of IL-10 rs1800871 and rs1800872 polymorphisms with breast cancer risk: a systematic review and meta-analysis[J]. Asian Pacific Journal of Cancer Prevention, 2018, 19(12): 3353-3359. DOI: 10.31557/apjcp.2018.19.12.3353. [24] NAING A, INFANTE J R, PAPADOPOULOS K P, et al. PEGylated IL-10 (Pegilodecakin)induces systemic immune activation, CD8+ T cell invigoration and polyclonal T cell expansion in cancer patients[J]. Cancer Cell, 2018, 34(5): 775-791. DOI: 10.1016/j.ccell.2018.10.007. [25] NAING A, PAPADOPOULOS K P, AUTIO K A, et al. Safety, antitumor activity, and immune activation of pegylated recombinant human interleukin-10 (AM0010) in patients with advanced solid tumors[J]. Journal of Clinical Oncology, 2016, 34(29): 3562-3569. DOI: 10.1200/JCO.2016.68.1106. [26] LU Z W, HU J Q, LIU W L, et al. IL-10 restores MHC class I expression and interferes with immunity in papillary thyroid cancer with hashimoto thyroiditis[J]. Endocrinology, 2020, 161(10): bqaa062. DOI: 10.1210/endocr/bqaa062. [27] OUYANG W J, O'GARRA A. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation[J]. Immunity, 2019, 50(4): 871-891. DOI: 10.1016/j.immuni.2019.03.020. [28] CHANG C M, LAM H Y P, HSU H J, et al. Interleukin-10: A double-edged sword in breast cancer[J].Tzu Chi Medical Journal, 2021, 33(3): 203-211. DOI: 10.4103/tcmj.tcmj_162_20. |
[1] | 何芳远, 苏权, 陈坤铨, 陈善栋, 姜勇, 罗明, 梁士楚. 基于功能性状及系统发育的桂林喀斯特石山群落构建[J]. 广西师范大学学报(自然科学版), 2023, 41(3): 171-181. |
[2] | 张丽萌, 李闰婷, 聂晓宁, 李玉华, 李林, 李亚蒙, 陈龙欣, 王林青. 生长抑素Ⅱ型受体SSTR2蛋白的理化性质及生物信息学分析[J]. 广西师范大学学报(自然科学版), 2023, 41(1): 164-173. |
[3] | 张春梅, 闫芳, 宋海, 张喜峰, 陈叶. 祁连山黄参叶片转录组测序及生物信息学分析[J]. 广西师范大学学报(自然科学版), 2022, 40(6): 247-256. |
[4] | 吕佳桦, 朱婵, 唐宗湘. 中药药性中“苦味”形成机制及生物学意义[J]. 广西师范大学学报(自然科学版), 2022, 40(5): 324-331. |
[5] | 陈莹, 周祖平, 邢兵, 蒲仕明. 基于CRISPR/Cas9系统构建Slfn2基因敲除的小鼠肺癌细胞系[J]. 广西师范大学学报(自然科学版), 2022, 40(4): 173-179. |
[6] | 周俊, 陈舒曼, 邢兵, 陈雅静, 李银玲, 何柳, 周祖平, 蒲仕明. 正常来源CD4+CD25+细胞在小鼠肺癌模型中的抗肿瘤作用[J]. 广西师范大学学报(自然科学版), 2022, 40(2): 191-199. |
[7] | 冯月婷, 韦周全, 黄中豪, 李友邦. 广西白头叶猴和黑叶猴理毛行为的比较研究[J]. 广西师范大学学报(自然科学版), 2022, 40(2): 208-217. |
[8] | 李冰, 李智, 杨溢龙. 基于词嵌入和长短期记忆网络的非功能软件需求分类[J]. 广西师范大学学报(自然科学版), 2021, 39(5): 110-121. |
[9] | 苏雷,李俊英. 国家重点生态功能区县域生态环境质量状况分级标准探讨[J]. 广西师范大学学报(自然科学版), 2019, 37(3): 196-202. |
[10] | 黄开娇, 肖飞雁. 具有Beddington-DeAngelis型功能性反应的随机捕食—被捕食系统[J]. 广西师范大学学报(自然科学版), 2018, 36(3): 32-40. |
[11] | 万福成,马宁,何向真. 融合事件特征及语义角色标注的藏文信息抽取技术[J]. 广西师范大学学报(自然科学版), 2018, 36(2): 18-23. |
[12] | 万雷,罗玉玲,黄星月. 脉冲神经网络硬件系统性能监测平台[J]. 广西师范大学学报(自然科学版), 2018, 36(1): 9-16. |
[13] | 刘佳丽,王冬翠,莫少锋,李宏周,陈真诚. 慢性吸烟者的脑静息态fMRI局部一致性研究[J]. 广西师范大学学报(自然科学版), 2016, 34(4): 151-155. |
[14] | 梅寒冰, 王威, 姚雪, 程联彪, 黄瑾. Hsp90抑制剂木犀草苷对非小细胞肺癌的体外抑制活性及作用机理研究[J]. 广西师范大学学报(自然科学版), 2015, 33(3): 91-97. |
[15] | 肖飞鹏, 李晖, 尹辉, 王月. 基于生态系统服务的青狮潭水库生态补偿研究[J]. 广西师范大学学报(自然科学版), 2014, 32(2): 162-167. |
|
版权所有 © 广西师范大学学报(自然科学版)编辑部 地址:广西桂林市三里店育才路15号 邮编:541004 电话:0773-5857325 E-mail: gxsdzkb@mailbox.gxnu.edu.cn 本系统由北京玛格泰克科技发展有限公司设计开发 |